GAO And Legislators Pushing HHS For Stronger 340B Oversight

The Government Accountability Office is proposing several recommendations to strengthen oversight of the 340B drug discount program, but says the HHS Health Resources and Services Administration wants to take other measures that GAO believes are insufficient.